22 January 2013
Marianna Gaça of British American Tobacco’s Group Research and Development has been successfully voted onto the Board of Directors of the American Society for Cellular and Computational Toxicology (ASCCT). ASCCT was established jointly by Institute of In Vitro Sciences (IIVS) and Physicians Committee for Responsible Medicine (PCRM) and launched at the IIVS Toxicology Forum, Maryland USA in October 2010.
‘I know that I can speak for my fellow board members when I say that we are all looking forward to working together to increase the membership and impact of the society’s activities’, said ASCCT secretary Kristie Sullivan of the PCRM.
The society has currently just over 100 individual members and 12 institutional sponsors, including scientists from the cosmetics, pharma, chemical and tobacco industries, CROs, SMEs, NGOs, federal agencies, journalists, regulators and animal welfare groups.
‘We are thrilled to be involved with the ASCCT at Board level and look forward to supporting and driving the ASCCT vision in the coming years’, said Marianna Gaça, BAT’s ASSCT Board representative. ‘We hope this opportunity will further encourage science collaboration to support our science base and increase awareness of emerging areas of science ‘.
British American Tobacco’s GR&D Centre has established an in-house research programme including the development of in vitro cellular and computational methodologies to facilitate the understanding of the biological effects of tobacco smoke and, in the future, help support the assessment of conventional and modified risk tobacco products.
ASCCT Officers include Roger Curren (IIVS) as president, Erin Hill (IIVS) as treasurer and Krisitie Sullivan (PCRM). Recently voted Board Directors include Marilyn Aardema (Marilyn Aardema Consulting, Inc. USA); Jack Fowle (formerly Environmental Protection Agency) and Thomas Hartung (Center for Alternatives for Animal Testing (CAAT), John Hopkins University USA).
NOTES TO EDITORS
+44 (0) 20 7845 2888 (24 hours)